Financials
- Market Capitalization 615.24 M
- Employee 371
- Founded 2008
- CEO N/A
- Website www.regenxbio.com
- Headquarter Maryland, United States
- FIGI BBG007Z9V591
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-3.16
ratio cours/chiffre d'affaires
3.61
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2741 | PRME Prime Medicine, Inc. - Common Stock | 3.57 USD | -0.56% | -2.46% | +23.53% | +13.69% | 647.52 M USD | ||
| 2767 | MPLT MapLight Therapeutics, Inc. - Common Stock | 13.31 USD | +2.62% | +6.74% | +3.58% | -29.95% | 617.29 M USD | ||
| 2771 | AUTL Autolus Therapeutics plc - American Depositary Shares | 2.31 USD | -1.70% | -4.15% | +34.30% | +59.31% | 614.84 M USD | ||
| 2774 | TECX Tectonic Therapeutic, Inc. - Common Stock | 31.22 USD | +4.28% | -16.55% | +12.30% | +82.04% | 610.33 M USD |